UPC Stock Analysis: Buy, Sell, or Hold?
UPC - Universe Pharmaceuticals Inc. Ordinary Shares
$4.40
-0.02 (-0.45%)
▼
5d:
+7.32%
30d:
+15.49%
90d:
-6.38%
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Get Alerted When UPC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: UPC shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: UPC shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: UPC is currently trading at $4.40, which is considered fair relative to its 30-day fair value range of $3.95 to $4.61.
Technical Outlook: Technically, UPC is showing sideways momentum. Immediate support is located at $4.00, while resistance sits at $4.56.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, UPC is showing sideways momentum. Immediate support is located at $4.00, while resistance sits at $4.56.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$3.95 -
$4.61
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
Fair Price Analysis
30-Day Fair Range
$3.95 -
$4.61
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$4.00
Resistance Level
$4.56
Current Trend
Sideways
Fundamental Context
Revenue Growth (YoY)
-29.0%
Earnings Growth (YoY)
-82.0%
Profit Margin
-49.9%
Last updated: February 02, 2026 10:58 AM ET
Data refreshes hourly during market hours. Next update: 11:58 AM
Data refreshes hourly during market hours. Next update: 11:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UPC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$180 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$154 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$83 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
